Showing results (81-90 of 320) with videos related to
Sort By:
Pageof 32
Mutation Research|February 1, 1989
Gene deletion, a mechanism of induced mutation by arabinosyl nucleosidesP Huang, M J Siciliano, W PlunkettCancer Treatment Reports|May 1, 1987
Effect of amsacrine on ara-CTP cellular pharmacology in human leukemia cells during high-dose cytarabine therapyW Plunkett, B Nowak, M J KeatingInternational Journal of STD & AIDS|February 21, 2013
Destructive spondyloarthropathy in a haemodialysis patient with HIV infection: case report and literature reviewV Agarwal, V GandhiClinical EEG (Electroencephalography)|April 1, 1982
Electroencephalograms in patients with progressive dialytic encephalopathyS Chokroverty, V GandhiHaematology and Blood Transfusion|January 1, 1990
Pharmacologically directed design of leukemia therapyW Plunkett, V Heinemann, E Estey, et al.Family and Consumer Sciences Research Journal|January 22, 2024
Life Quality of University Students From Immigrant Families in the United StatesFarin Bakhtiari, Aprile D Benner, Scott W PlunkettJournal of Health Psychology|May 5, 2018
Factor structure and validity of the Affective Style QuestionnaireRui Jiang, Scott W Plunkett, Andrew T AinsworthMolecular Pharmacology|March 22, 2001
2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine: a novel anticancer nucleoside analog that causes both DNA strand breaks and G(2) arrestA Azuma, P Huang, A Matsuda, et al.Cancer Research|August 15, 1991
Plasma and cerebrospinal fluid pharmacokinetics of 1-beta-D-arabinofuranosylcytosine and 1-beta-D-arabinofuranosyluracil following the repeated intravenous administration of high- and intermediate-dose 1-beta-D-arabinofuranosylcytosineL E Damon, W Plunkett, C A LinkerBiochemical Pharmacology|May 30, 2001
Cellular pharmacokinetics and pharmacodynamics of the deoxycytidine analog 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine (CNDAC)A Azuma, P Huang, A Matsuda, et al.Pageof 32